mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.1 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |